Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume.

نویسندگان

  • N Lawrence
  • N Levy
چکیده

having this complication depended upon the method of measurement. What was particularly striking was that there was no overlap between the groups defined by the two different methods. Hence, we do not know what our incidence of clinically important PONV is, should we use VAS75, PONVIS or both? Whatever the incidence, it occurs against the background of our best ever finding of 67% adherence to our PONV prophylaxis guidelines so, as we continue to audit this, it is important for us to have a reproducible method of measuring the incidence of severe PONV. Myles, Wengritzky and co-workers have made useful and important contributions to defining the severity of PONV. In clinical practice, we are never going to be able to eliminate PONV entirely and a more realistic hope will be to reduce the severity, such that the number of patients suffering enough to impair their recovery is minimized. We do however need to be able to capture these patients accurately, reliably, and reproducibly. Translating their findings to our in-patient population indicates that this important goal has not yet been reached. validation of a postoperative nausea and vomiting intensity score. Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review. Editor—We thank Dr Brampton and colleagues for their interest in our studies and applaud the Aberdeen Royal Infirmary (ARI) anaesthetic department's audit practices. The most compelling observation of this audit was the moderately high incidence of any postoperative nausea and vomiting (PONV), but only a small proportion of this could be rated as clinically important. That is, most episodes of PONVare mild and often transient in nature. This reality can be likened to the presence of pain after ambulatory surgery, with most of it being well controlled and only of mild intensity. Why should we aim to eliminate PONVentirely, when it seems to not be a clinical problem for the majority of patients? With respect to the different results obtained when using our two different PONV severity scales, we would recommend the 2012 version 1 because our own experience was that the former scale was ambiguous for some clinicians and a sizeable proportion of patients. As outlined in our second publication, 1 we chose to revise the PONV severity scale because of this am-biguity—we thus recommend the revised, simplified scale for future use. The validation cohort used in our original study included patients undergoing day stay and minor surgery. …

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Distinctive effect of 6% hydroxyethyl starch 130/0.4 (Voluven) infusion on pediatric patients with congenital heart disease.

OBJECTIVE It has not been clear that Voluven (6% hydroxyethyl starch 130/0.4) may be administered in pediatric patients safely. The purpose of this study was to determine if Voluven could be used for blood volume expansion and hypovolemia prevention in pediatric patients with congenital heart disease. PATIENTS AND METHODS 50 pediatric patients with congenital heart disease were recruited in t...

متن کامل

Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin

INTRODUCTION This study compared the effects of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin on oxidative stress and the inflammatory response in a rodent hemorrhagic shock model. METHODS Sodium pentobarbital-anesthetized adult male Wistar rats (200 g to 220 g) were subjected to a severe volume-controlled hemorrhage using arterial blood withdrawal (30 mL/...

متن کامل

Voluven, a new colloid solution.

Hydroxyethyl starch (HES) 130/0.4 (Voluven, Fresenius/Hospira, Germany) is indicated for the treatment and prophylaxis of hypovolemia. As the Voluven molecule is smaller than those of other available hydroxyethyl starch products, it is associated with less plasma accumulation and can be safely used in patients with renal impairment. Previous studies have demonstrated that Voluven has comparable...

متن کامل

Intra-operative hydroxyethyl starch is not associated with post-craniotomy hemorrhage

BACKGROUND Intraoperative intravascular volume expansion with hydroxyethyl starch-based colloids is thought to be associated with an increased risk of post-craniotomy hemorrhage. Evidence for this association is limited. Associations between resuscitation with hydroxyethyl starch and risk of repeat craniotomy for hematoma evacuation were examined. METHODS Using a retrospective cohort of neuro...

متن کامل

Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

BACKGROUND Several plasma volume expander alternatives exist to enhance intravascular volume status in patients undergoing surgery. The optimal intravascular volume expander in the perioperative setting is currently unknown. Low molecular weight hetastarch, Voluven® (130/0.4), may have a better safety profile than high molecular weight hetastarch, Hextend® (450/0.7). We examined the clinical an...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • British journal of anaesthesia

دوره 111 4  شماره 

صفحات  -

تاریخ انتشار 2013